MedPath

Prof. Dr. med. Axel Ekkernkamp

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

2 Phases

Phase 2:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 2
1 (50.0%)

Preventing Recurrences of Chronic Subdural Hematoma in Adult Patients by Middle Meningeal Artery Embolization

Not Applicable
Recruiting
Conditions
Hematoma, Subdural, Chronic
First Posted Date
2022-04-14
Last Posted Date
2025-03-30
Lead Sponsor
Unfallkrankenhaus Berlin
Target Recruit Count
154
Registration Number
NCT05327933
Locations
🇩🇪

Unfallkrankenhaus Berlin, Berlin, Germany

Healing of Burns and the Effect of Shockwave Therapy on the Recovery of Skin Grafts

Phase 2
Completed
Conditions
Burn Wound and Skin Graft Healing
First Posted Date
2010-11-17
Last Posted Date
2010-11-18
Lead Sponsor
Unfallkrankenhaus Berlin
Target Recruit Count
100
Registration Number
NCT01242423
Locations
🇩🇪

Unfallkrankenhaus Berlin, Berlin, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.